In this multi-institution randomized trial, patients with heart failure underwent daily telemonitoring and standard care or just standard care. At 1 year, fewer patients in the telemonitoring group had worsened composite score (19% vs 27%) and experienced fewer deaths (10 vs 27 pts).
You are here:
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
Submitted by: Mark Ferguson
Source: The Lancet
Keywords:
Author(s): Gerhard Hindricks, Milos Taborsky, Michael Glikson, Ullus Heinrich, Burghard Schumacher, Amos Katz, Johannes Brachmann, Thorsten Lewalter, Andreas Goette, Michael Block, Josef Kautzner, Stefan Sack, Daniela Husser, Christopher Piorkowski, Peter Søgaard, for the IN-TIME study group
